The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation

Tissue Engineering - Part A

Volumn 15, Issue 8, 2009, Pages 2123-2133

  Li, Guangheng ^a   Corsi Payne, Karin ^a   Zheng, Bo ^a   Usas, Arvydas ^a   Peng, Hairong ^b   Huard, Johnny ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOMINERALIZATION; CALCIFICATION (BIOCHEMISTRY); CELL MEMBRANES; CELL PROLIFERATION; GENETIC ENGINEERING; PEPTIDES; SELF ASSEMBLY; TISSUE ENGINEERING;

BENEFICIAL EFFECTS; BONE FORMATION; BONE HEALING; BONE MORPHOGENETIC PROTEIN-4; BONE MORPHOGENETIC PROTEINS; CELL TYPES; CELL-BASED; CELLULAR PROLIFERATIONS; DETRIMENTAL EFFECTS; ECTOPIC BONES; GENE THERAPY; GROWTH FACTOR; IN-VITRO; IN-VIVO; SYNERGISTIC EFFECT; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BONE;

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; GROWTH FACTOR; VASCULOTROPIN;

ARTICLE; BONE MINERALIZATION; CALCIFICATION; CELL BASED GENE THERAPY; CELL PROLIFERATION; CELL SURVIVAL; DOSE RESPONSE; ENCHONDRAL OSSIFICATION; FRACTURE HEALING; GLUTEOFEMORAL MUSCLE; IN VITRO STUDY; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SCID MOUSE; TISSUE ENGINEERING;

MUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CALCIFICATION, PHYSIOLOGIC; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; CHORISTOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENETIC ENGINEERING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NIH 3T3 CELLS; OSTEOGENESIS; RETROVIRIDAE; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68749095858     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0214     Document Type: Article

References (25)

1. Ferguson, C., Alpern, E., Miclau, T., and Helms, J.A. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87, 57, 1999.
2. Sato, M., Yasui, N., Nakase, T., Kawahata, H., Sugimoto, M., Hirota, S., Kitamura, Y., Nomura, S., and Ochi, T. Expression of bone matrix proteins mRNA during distraction osteo-genesis. J Bone Miner Res 13, 1221, 1998.
3. Vortkamp, A., Pathi, S., Peretti, G.M., Caruso, E.M., Zaleske, D.J., and Tabin, C.J. Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 71, 65, 1998.
4. Carrington, J.L., and Reddi, A.H. Parallels between development of embryonic and matrix-induced endochondral bone. Bioessays 13, 403, 1991.
5. Zelzer, E., Mamluk, R., Ferrara, N., Johnson, R.S., Schipani, E., and Olsen, B.R. VEGFA is necessary for chondrocyte survival during bone development. Development 131, 2161, 2004.
6. Horner, A., Bishop, N.J., Bord, S., Beeton, C., Kelsall, A.W., Coleman, N., and Compston, J.E. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 194 (Pt 4), 519, 1999.
7. Carlevaro, M.F., Cermelli, S., Cancedda, R., and Descalzi Cancedda, F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113 (Pt 1), 59, 2000.
8. Yee, G., Yu, Y., Walsh, W.R., Lindeman, R., and Poole, M.D. The immunolocalisation of VEGF in the articular cartilage of sheep mandibular condyles. J Craniomaxillofac Surg 31, 244, 2003.
9. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623, 1999.
10. Midy, V., and Plouet, J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199, 380, 1994.
11. Harper, J., Gerstenfeld, L.C., and Klagsbrun, M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81, 82, 2001.
12. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., and Filvaroff, E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99, 9656, 2002.
13. Mori, S., Yoshikawa, H., Hashimoto, J., Ueda, T., Funai, H., Kato, M., and Takaoka, K. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone mor-phogenetic protein-2. Bone 22, 99, 1998.
14. Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111, 61, 2002.
15. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
16. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., and Huard, J. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
17. Peng, II., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., and Huard, J. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
18. Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., and Collins, M.K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 69, 7430, 1995.
19. Peng, II., Chen, S.T., Wergedal, J.E., Polo, J.M., Yee, J.K., Lau, K.H., and Baylink, D.J. Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther 4, 95, 2001.
20. Li, G., Peng, H., Corsi, K., Usas, A., Olshanski, A., and Huard, J. Differential effect of BMP4 on NIH/3T3 and C2C12 cells: implications for endochondral bone formation. J Bone Miner Res 20, 1611, 2005.
21. Raida, W., Clement, J.H., Leek, R.D., Ameri, K., Bicknell, R., Niederwieser, D., and Harris, A.L. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131, 741, 2005.
22. Zelzer, E., and Olsen, B.R. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65, 169, 2005.
23. Lee, J.W., Bae, S.H., Jeong, J.W., Kim, S.H., and Kim, K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36, 1, 2004.
24. Pugh, C.W., and Ratcliffe, P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9, 677, 2003.
25. Semenza, G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721, 2003.